Goldberg Andrew D. 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 29, 2026

AI-generated summary of this filing

Updated Jun 29, 2026

Tarsus (TARS) Director Andrew Goldberg Receives Options & RSUs

What Happened

Andrew D. Goldberg, a non‑employee director of Tarsus Pharmaceuticals (TARS), received two awards on June 25, 2026: a grant of 3,837 derivative shares (stock options) and 2,417 Restricted Stock Units (RSUs). Both grants were recorded at $0.00 (no cash paid). These are awards/compensation grants, not open‑market purchases or sales.

Key Details

Transaction date: 2026-06-25; Filing date: 2026-06-29.
Grants: 3,837 options (derivative) @ $0.00; 2,417 RSUs @ $0.00.
Vesting: Options vest in full on the one‑year anniversary of grant (F1). RSUs convert to one share each and vest in full on the one‑year anniversary of grant (F2, F3), subject to continuous service.
Shares owned after transaction: not specified in the provided filing excerpt.
Filing timeliness: Form 4 was filed June 29, 2026. For a June 25 transaction this filing date is within the typical two‑business‑day Form 4 reporting window (i.e., appears timely).
Nature of transaction: Award/Grant (code A); both entries are derivative/contingent (options and RSUs).

Context

The options were granted (not exercised), and the RSUs are a contingent right to receive shares on vesting — neither transaction resulted in immediate share sales or purchases in the open market. These types of grants are common director compensation and should be viewed as compensation awards rather than a direct bullish or bearish insider market signal.

Form 4

Period: 2026-06-25

Director

Transactions

Award
Stock Option (right to buy)
[F1]
2026-06-25+3,837→ 3,837 total
Exercise: $64.34Exp: 2036-06-24→ Common Stock (3,837 underlying)
Award
Restricted Stock Units
[F2][F3]
2026-06-25+2,417→ 2,417 total
→ Common Stock (2,417 underlying)

Footnotes (3)

[F1]Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.
[F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
[F3]RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Signature

/s/ Scott Sieckert, Attorney-in-Fact|2026-06-29

1 file